India Supreme Court Rules in Favor of Merck in Diabetes Drug Patent Suit

The Supreme Court of India has barred Mumbai-based Glenmark Pharmaceuticals from making and selling generic versions of U.S. drugmaker Merck's diabetes drugs, Januvia and Janumet.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news